Assignee
FOREST LABORATORIES
US·11 granted patents·19 pending applications·2,027 citations·filing 1979–2009
Top patents by PatentIndex Score
30 records- 0197US4389393ASustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcelluloseFOREST LABORATORIES·Filed 1982·Granted Jun 21, 1983·654 cites·10 claims
- 0297US4369172AProlonged release therapeutic compositions based on hydroxypropylmethylcelluloseFOREST LABORATORIES·Filed 1981·Granted Jan 18, 1983·549 cites·38 claims
- 0394US4226849ASustained release therapeutic compositionsFOREST LABORATORIES·Filed 1979·Granted Oct 7, 1980·140 cites·9 claims
- 0493US4795327AControlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactantsFOREST LABORATORIES·Filed 1984·Granted Jan 3, 1989·125 cites·10 claims
- 0593US4540566AProlonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcelluloseFOREST LABORATORIES·Filed 1984·Granted Sep 10, 1985·119 cites·9 claims
- 0691US4482534ANitroglycerin preparationsFOREST LABORATORIES·Filed 1983·Granted Nov 13, 1984·78 cites·28 claims
- 0788US4357469ACarrier base material for prolonged release therapeutic compositionsFOREST LABORATORIES·Filed 1981·Granted Nov 2, 1982·83 cites·3 claims
- 0885US4983398ASustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylatesFOREST LABORATORIES·Filed 1988·Granted Jan 8, 1991·78 cites·10 claims
- 0983US5527822AMethod of treatment of traumatic brain injuryFOREST LABORATORIES·Filed 1993·Granted Jun 18, 1996·112 cites·12 claims
- 1082US4533540ANitroglycerin-containing polymeric matrix for sustained release on topical applicationFOREST LABORATORIES·Filed 1984·Granted Aug 6, 1985·42 cites·12 claims
- 1175US4849229AControlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactantsFOREST LABORATORIES·Filed 1988·Granted Jul 18, 1989·47 cites·5 claims
- 1263US2010028427A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LABORATORIES·Filed 2009·Application pending·0 cites
- 1363US2005149569A1Electronic lab notebookFOREST LABORATORIES·Filed 2004·Application pending·0 cites
- 1457US2007065512A1Modified and immediate release formulations of memantineFOREST LABORATORIES·Filed 2006·Application pending·0 cites
- 1555US2006205822A11-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affectFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 1654US2006198884A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 1753US2006002999A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 1853US2004186122A1Method of treating acute pain with a unitary dosage form comprising ibuprofin and oxycodoneFOREST LABORATORIES·Filed 2003·Application pending·0 cites
- 1953US2005014743A1Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disordersFOREST LABORATORIES·Filed 2004·Application pending·0 cites
- 2049US2006165789A1Lercanidipine modified release compositionsFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 2148US2006134212A1Lercanidipine immediate release compositionsFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 2247US2007117826A1Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinoneFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 2346US2005059690A1Method of treating acute pain with a unitary dosage form comprising ibuprofen and oxycodoneFOREST LABORATORIES·Filed 2004·Application pending·0 cites
- 2445US2006035888A1Memantine as adjunctive treatment to atypical antipsychotic in schizophrenia patientsFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 2545US2006211650A1Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereofFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 2644US2005113458A1Use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic a-beta peptides in amyloidopathiesFOREST LABORATORIES·Filed 2004·Application pending·0 cites
- 2744US2007134322A1Modified and pulsatile release pharmaceutical formulations of escitalopramFOREST LABORATORIES·Filed 2006·Application pending·0 cites
- 2843US2007112075A1Stable pharmaceutical formulations containing escitalopram and bupropionFOREST LABORATORIES·Filed 2006·Application pending·0 cites
- 2941US2006020042A1Memantine for the treatment of mild and mild to moderate Alzheimer's diseaseFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 3035US2005203191A11-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's diseaseFOREST LABORATORIES·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →